|Photo: Ann Johansson|
It has been more than 30 years since I came to UCLA, after completing my MD, PhD and internship at Georgetown University. So much has transpired over those decades, both for me personally and for UCLA as an institution.
When I arrived for my residency in neurology, UCLA physicians had reported the very first cases of AIDS. Today, the UCLA AIDS Institute is among the world’s foremost research centers, seeking answers to the prevention and treatment of this illness. In the intervening years, we established our heart- and liver-transplant programs, and now we are recognized as world leaders in organ transplantation. The same can be said of our world-class reputation in imaging — enabling us to actually see the structure and function of the human body in health and disease. We are delivering better health and greater value to more people and deploying high-value innovations through collaborations such as UCLA’s Institute for Innovation. The school of medicine, at just 64 years old, is now among the country’s top-ranking institutions of medical learning. Our faculty have won a Nobel Prize and been elected to the prestigious National Academy of Sciences, among other high honors.
It was in this period of extraordinary growth that I completed my training and joined the faculty, established the Ahmanson-Lovelace Brain Mapping Center and became a department chair. I have been an associate vice chancellor and executive vice dean. All these perspectives have given me a clear view of what a unique and extraordinary institution and community we have here at UCLA.
Now, it is a great honor and privilege to assume the roles of dean of the David Geffen School of Medicine at UCLA, vice chancellor for UCLA Health Sciences and CEO of UCLA Health. My predecessors — Drs. A. Eugene Washington and David T. Feinberg, and those who came before them — have constructed an enduring foundation of excellence and a solid vision to carry forward our missions of teaching, research, patient care and community engagement. Their departure represents major changes for us, but, with the long-standing relationships we have built and our strategic plans, I am confi dent that this transition will be smooth, and we will move ahead with full momentum.
Change is always paired with opportunity. I look forward to continuing to work with my many colleagues at UCLA and our supporters and alumni throughout the community to continue building the future. People are the bedrock of all great institutions. Our faculty, trainees and staff are the reason for our success, producing the discoveries that transform medicine, teaching the next generations of scientists and physicians and providing the exceptional patient-centered and integrated care for which UCLA has become known. They connect us with our communities — with you, the readers of this publication — near and far.
I am excited and honored to serve in this new role, partnering with you as we continue our path forward to make UCLA the future of medicine.
John C. Mazziotta, MD (RES ’81, FEL ’83), PhD
Vice Chancellor, UCLA Health Sciences
Dean, David Geffen School of Medicine at UCLA
CEO, UCLA Health